DUBLIN--(BUSINESS WIRE)--The "Pen Needles - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.
Pen Needles market worldwide is projected to grow by US$2.1 Billion, driven by a compounded growth of 10.9%.
Standard Pen Needles, one of the segments analyzed and sized in this study, displays the potential to grow at over 10.2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$2.8 Billion by the year 2025, Standard Pen Needles will bring in healthy gains adding significant momentum to global growth.
Representing the developed world, the United States will maintain a 9.7% growth momentum.
Within Europe, which continues to remain an important element in the world economy, Germany will add over US$84.6 Million to the region's size and clout in the next 5 to 6 years. Over US$140.3 Million worth of projected demand in the region will come from other emerging Eastern European markets.
In Japan, Standard Pen Needles will reach a market size of US$153.6 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 14% over the next couple of years and add approximately US$499.9 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.
Competitors identified in this market include the following, among others:
- Arkray, Inc. (Japan)
- Artsana S.p.A. (Italy)
- B. Braun Melsungen AG (Germany)
- Becton, Dickinson and Company (USA)
- GlucoRx Ltd. (United Kingdom)
- Htl-Strefa S.A. (Poland)
- Novo Nordisk A/S (Denmark)
- Owen Mumford Ltd. (United Kingdom)
- Terumo Corporation (Japan)
- UltiMed Inc. (Ulticare) (USA)
- Ypsomed AG (Switzerland)
- Allison Medical (USA)
For more information about this report visit https://www.researchandmarkets.com/r/qbavl6
